UNIVERSAL HEALTH SERVICES-B (UHS)
US9139031002 - Common Stock
Overall UHS gets a fundamental rating of 6 out of 10. We evaluated UHS against 113 industry peers in the Health Care Providers & Services industry. While UHS has a great profitability rating, there are some minor concerns on its financial health. UHS is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make UHS a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year UHS was profitable.
UHS had a positive operating cash flow in the past year.
In the past 5 years UHS has always been profitable.
UHS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 7.15%, UHS belongs to the best of the industry, outperforming 92.04% of the companies in the same industry.
UHS has a better Return On Equity (15.53%) than 87.61% of its industry peers.
UHS has a Return On Invested Capital of 9.51%. This is amongst the best in the industry. UHS outperforms 86.73% of its industry peers.
UHS had an Average Return On Invested Capital over the past 3 years of 7.81%. This is in line with the industry average of 8.10%.
The last Return On Invested Capital (9.51%) for UHS is above the 3 year average (7.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.15% | ||
| ROE | 15.53% | ||
| ROIC | 9.51% |
ROA(3y)5.9%
ROA(5y)6.33%
ROE(3y)13.11%
ROE(5y)13.8%
ROIC(3y)7.81%
ROIC(5y)8.4%
1.3 Margins
UHS has a better Profit Margin (6.65%) than 87.61% of its industry peers.
In the last couple of years the Profit Margin of UHS has declined.
Looking at the Operating Margin, with a value of 9.99%, UHS belongs to the top of the industry, outperforming 85.84% of the companies in the same industry.
UHS's Operating Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.99% | ||
| PM (TTM) | 6.65% | ||
| GM | N/A |
OM growth 3Y-11.19%
OM growth 5Y-5.48%
PM growth 3Y-14.86%
PM growth 5Y-7.03%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
UHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, UHS has less shares outstanding
Compared to 5 years ago, UHS has less shares outstanding
UHS has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of UHS is 4.87, which is a neutral value as it means it would take UHS, 4.87 years of fcf income to pay off all of its debts.
UHS has a better Debt to FCF ratio (4.87) than 79.65% of its industry peers.
A Debt/Equity ratio of 0.70 indicates that UHS is somewhat dependend on debt financing.
UHS has a Debt to Equity ratio (0.70) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | 4.87 | ||
| Altman-Z | N/A |
ROIC/WACC1.28
WACC7.43%
2.3 Liquidity
UHS has a Current Ratio of 1.39. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of UHS (1.39) is comparable to the rest of the industry.
UHS has a Quick Ratio of 1.28. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
UHS has a Quick ratio (1.28) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.28 |
3. Growth
3.1 Past
UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.24%, which is quite impressive.
UHS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.08% yearly.
The Revenue has grown by 9.93% in the past year. This is quite good.
Measured over the past years, UHS shows a small growth in Revenue. The Revenue has been growing by 5.80% on average per year.
EPS 1Y (TTM)42.24%
EPS 3Y-1.77%
EPS 5Y2.08%
EPS Q2Q%45.49%
Revenue 1Y (TTM)9.93%
Revenue growth 3Y7.31%
Revenue growth 5Y5.8%
Sales Q2Q%11.23%
3.2 Future
UHS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.27% yearly.
UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.15% yearly.
EPS Next Y52.29%
EPS Next 2Y30.91%
EPS Next 3Y23.89%
EPS Next 5Y15.27%
Revenue Next Year10.39%
Revenue Next 2Y8.35%
Revenue Next 3Y7.48%
Revenue Next 5Y5.15%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
UHS is valuated correctly with a Price/Earnings ratio of 13.31.
UHS's Price/Earnings ratio is rather cheap when compared to the industry. UHS is cheaper than 88.50% of the companies in the same industry.
When comparing the Price/Earnings ratio of UHS to the average of the S&P500 Index (28.65), we can say UHS is valued rather cheaply.
With a Price/Forward Earnings ratio of 10.93, the valuation of UHS can be described as very reasonable.
Based on the Price/Forward Earnings ratio, UHS is valued cheaper than 88.50% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.56, UHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.31 | ||
| Fwd PE | 10.93 |
4.2 Price Multiples
83.19% of the companies in the same industry are more expensive than UHS, based on the Enterprise Value to EBITDA ratio.
86.73% of the companies in the same industry are more expensive than UHS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.64 | ||
| EV/EBITDA | 8.28 |
4.3 Compensation for Growth
UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
UHS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as UHS's earnings are expected to grow with 23.89% in the coming years.
PEG (NY)0.25
PEG (5Y)6.41
EPS Next 2Y30.91%
EPS Next 3Y23.89%
5. Dividend
5.1 Amount
With a yearly dividend of 0.40%, UHS is not a good candidate for dividend investing.
UHS's Dividend Yield is a higher than the industry average which is at 3.16.
With a Dividend Yield of 0.40, UHS pays less dividend than the S&P500 average, which is at 2.23.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
5.2 History
The dividend of UHS is nicely growing with an annual growth rate of 14.84%!
UHS has been paying a dividend for at least 10 years, so it has a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)14.84%
Div Incr Years0
Div Non Decr Years3
5.3 Sustainability
UHS pays out 5.25% of its income as dividend. This is a sustainable payout ratio.
The dividend of UHS is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP5.25%
EPS Next 2Y30.91%
EPS Next 3Y23.89%
UNIVERSAL HEALTH SERVICES-B
NYSE:UHS (11/21/2024, 4:15:00 PM)
After market: 197.61 0 (0%)197.61
+0.09 (+0.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap13.05B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.31 | ||
| Fwd PE | 10.93 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.25
PEG (5Y)6.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.15% | ||
| ROE | 15.53% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 9.99% | ||
| PM (TTM) | 6.65% | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.7 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.28 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)42.24%
EPS 3Y-1.77%
EPS 5Y
EPS Q2Q%
EPS Next Y52.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.93%
Revenue growth 3Y7.31%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y